Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Revascularization Stories

2012-02-02 07:34:00

ATLANTA, Feb. 2, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today that 2011 fourth quarter and year end financial results will be released on Thursday, February 16, 2012. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and...

2011-11-21 11:31:00

ATLANTA, Nov. 21, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it will participate in the upcoming 23rd Annual Piper Jaffray Health Care Conference on Wednesday, November 30, 2011 at The New York Palace Hotel in New York City. Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present at 4:00 p.m. Eastern Time. CryoLife's...

2011-11-03 07:34:00

ATLANTA, Nov. 3, 2011 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present in the upcoming Lazard Capital Markets Eighth Annual Healthcare Conference on Tuesday, November 15, 2011 at 3:00 pm ET in New York City. CryoLife is also scheduled to present at the Stephens, Inc Fall...

2011-02-09 13:35:17

Coated stents superior to bare metal stents in reducing restenosis A systematic review of medical evidence has determined drug-eluting stents (DES) outperform bare metal stents (BMS) for revascularization of chronic total occlusions. Researchers found coated stents reduce restenosis and target revascularization, offering a safe approach with similar adverse events as BMS. Full findings are available in the February issue of Catheterization and Cardiovascular Interventions, a journal published...

2011-01-17 22:13:02

Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction (heart attack). The findings were published online in Cardiovascular Revascularization Medicine and will be presented at The Sixth International Conference on Cell Therapy for Cardiovascular Disease at Columbia University Medical Center, New York City, on January 20, 2011....

2010-11-16 19:25:38

American Heart Association meeting report Treatment that included early surgical procedures to open blocked arteries resulted in better blood flow to the heart than aggressive medical treatment alone in patients with both diabetes and heart disease, according to a study presented at the American Heart Association's Scientific Sessions 2010. Previously, researchers in BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) found that over five years there were no fewer deaths...

2010-09-22 17:38:37

Researchers from the Cardiac & Vascular Institute at NYU Langone Medical Center will present at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium on September 21-25, 2010 in Washington, DC. They will be available for interviews during the conference. Louis Miller, MDInterventional Cardiology Fellow, Department of Medicine, Leon H. Charney Division of Cardiology at NYU Langone Medical Center Wednesday, September 22, 2010 Presenter"¢Very Long-term Clinical...

2010-07-15 06:00:00

IRVINE, Calif., July 15 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (OTCQB: CGCP) today announced that Executive Chairman Paul J. McCormick will present a corporate overview during the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on Tuesday, July 20, 2010, at 11:00 a.m. Eastern time (8:00 a.m. Pacific time). The live audio and slide presentation webcast at will be available at www.cardiogenesis.com; click on investors. The webcast will also be available from...

2010-07-14 15:25:00

NEW YORK, July 14 /PRNewswire-FirstCall/ -- Cardiogenesis Corp. (Other OTC: CGCP) announces the following Webcast: What: LHA Life Sciences & Med Tech Day 2010 Presentation When: July 20, 2010 @ 11:00 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=160338 Live over the Internet --Simply log on to the web at the address How: above. Contact: Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.com If you are unable to...

2010-06-23 06:00:00

IRVINE, Calif., June 23 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (OTCQB: CGCP), today announced that it is scheduled to present at the New York OneMedForum Emerging Company Finance Conference to be held June 29-30, 2010 at the Roosevelt Hotel. Executive Chairman Paul J. McCormick will present a corporate overview on Wednesday, June 30, 2010 at 9:40 am Eastern Time (6:40 am Pacific Time) and meet one-on-one with investors during the conference. The presentation and a link to...